Uremic Pruritus

Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients

A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus

A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Phase 1 Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus

Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis

The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus.

Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus

The Efficacy of Hemp-containing Cream Versus Placebo in the Treatment of Uremic Pruritus

AST-120 in Hemodialysis Patients With Uremic Pruritus

Acupressure on Uremic Pruritus and Sleep Quality Among Patients Receiving Hemodialysis

A Study of Thalidomide in the Treatment of Refractory Uremic Pruritus

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hemodialysis

Using of Extra Virgin Olive Oil in Hemodialysis Patients to Improve Pruritus and Sleep Disorders

Intermediate-Size Patient Population Expanded Access Program for Intravenous Difelikefalin

CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis